JP2023508616A5 - - Google Patents
Info
- Publication number
- JP2023508616A5 JP2023508616A5 JP2022565737A JP2022565737A JP2023508616A5 JP 2023508616 A5 JP2023508616 A5 JP 2023508616A5 JP 2022565737 A JP2022565737 A JP 2022565737A JP 2022565737 A JP2022565737 A JP 2022565737A JP 2023508616 A5 JP2023508616 A5 JP 2023508616A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962956033P | 2019-12-31 | 2019-12-31 | |
| US62/956,033 | 2019-12-31 | ||
| PCT/US2020/067729 WO2021138600A1 (en) | 2019-12-31 | 2020-12-31 | Nanoparticle systems to stimulate and maintain immune system responsiveness at treatment sites |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023508616A JP2023508616A (ja) | 2023-03-02 |
| JP2023508616A5 true JP2023508616A5 (https=) | 2024-01-12 |
| JPWO2021138600A5 JPWO2021138600A5 (https=) | 2024-01-12 |
Family
ID=76685916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022565737A Pending JP2023508616A (ja) | 2019-12-31 | 2020-12-31 | 治療部位での免疫系応答性を刺激し維持するためのナノ粒子システム |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230331804A1 (https=) |
| EP (1) | EP4085137A4 (https=) |
| JP (1) | JP2023508616A (https=) |
| KR (1) | KR20220130712A (https=) |
| CN (1) | CN115135764A (https=) |
| AU (1) | AU2020417305A1 (https=) |
| BR (1) | BR112022013068A2 (https=) |
| CA (1) | CA3162629A1 (https=) |
| IL (1) | IL294441A (https=) |
| MX (1) | MX2022008183A (https=) |
| WO (1) | WO2021138600A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111629715A (zh) | 2018-01-18 | 2020-09-04 | 弗莱德哈钦森癌症研究中心 | 通过调节细胞活化状态改变体内免疫细胞的炎症状态 |
| CN113166783B (zh) | 2018-10-09 | 2024-10-11 | 不列颠哥伦比亚大学 | 包含无有机溶剂和去污剂的转染活性囊泡的组合物和系统以及与之相关的方法 |
| IL322315A (en) | 2019-05-14 | 2025-09-01 | Provention Bio Inc | Methods and preparations for preventing type 1 diabetes |
| AU2021287998B2 (en) | 2020-06-11 | 2026-03-12 | Benaroya Research Institute At Virginia Mason | Methods and compositions for preventing type 1 diabetes |
| US12565529B2 (en) | 2021-05-24 | 2026-03-03 | Provention Bio, Inc. | Methods for treating type 1 diabetes |
| WO2023081644A1 (en) * | 2021-11-02 | 2023-05-11 | Engage Biologics Inc. | Materials and methods for treatment with mrna encoding multispecific binding molecules |
| EP4561537A2 (en) * | 2022-07-27 | 2025-06-04 | Trustees Of Tufts College | Lipid nanoparticles for immunotherapy |
| CN116003627B (zh) * | 2022-09-16 | 2025-05-13 | 四川大学华西医院 | NKG2D-NKp46细胞接合器分子及其用途 |
| CN116874600B (zh) * | 2023-07-13 | 2024-07-05 | 浙江大学 | 来自纳米抗体可靶向cd163受体的短肽的制备方法及其应用 |
| WO2025026553A1 (en) * | 2023-08-02 | 2025-02-06 | BioNTech SE | Agents and methods for targeted delivery to cells |
| WO2025128615A1 (en) * | 2023-12-12 | 2025-06-19 | Seagen Inc. | Multispecific egfr antibodies and use in the treatment of cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2294579C (en) * | 1997-06-23 | 2007-10-09 | Sequus Pharmaceuticals, Inc. | Liposome-entrapped polynucleotide composition and method |
| WO1999064074A1 (en) * | 1998-06-11 | 1999-12-16 | The Trustees Of The University Of Pennsylvania | Methods and compositions for delivering proteins to macrophage cells and cells of macrophage derived lineage |
| WO2016004043A1 (en) * | 2014-06-30 | 2016-01-07 | Blend Therapeutics, Inc. | Targeted conjugates and particles and formulations thereof |
| CN119564879A (zh) * | 2015-08-18 | 2025-03-07 | 乐天医药生技股份有限公司 | 用于光免疫疗法的组合物、联用及相关方法 |
| AU2016308286B2 (en) * | 2015-08-18 | 2022-04-07 | Rakuten Medical, Inc. | Phthalocyanine dye conjugates and their storage |
| EP3353309A4 (en) * | 2015-09-25 | 2019-04-10 | Tarveda Therapeutics, Inc. | COMPOSITIONS AND METHOD FOR GENERIC EDITING |
| AU2017313806B2 (en) * | 2016-08-17 | 2023-07-20 | Orbis Health Solutions Llc | Tumor-targeting bead vectors and methods of using the same |
| CN111629715A (zh) * | 2018-01-18 | 2020-09-04 | 弗莱德哈钦森癌症研究中心 | 通过调节细胞活化状态改变体内免疫细胞的炎症状态 |
| CR20200459A (es) * | 2018-04-13 | 2020-11-11 | Hoffmann La Roche | Moléculas de unión a antígeno dirigidas a her2 que comprendan 4-1bbl |
| JP2021523110A (ja) * | 2018-05-01 | 2021-09-02 | フレッド ハッチンソン キャンサー リサーチ センター | 遺伝子発現のためのナノ粒子及びその使用 |
-
2020
- 2020-12-31 CN CN202080091519.9A patent/CN115135764A/zh active Pending
- 2020-12-31 KR KR1020227026301A patent/KR20220130712A/ko active Pending
- 2020-12-31 BR BR112022013068A patent/BR112022013068A2/pt unknown
- 2020-12-31 CA CA3162629A patent/CA3162629A1/en active Pending
- 2020-12-31 WO PCT/US2020/067729 patent/WO2021138600A1/en not_active Ceased
- 2020-12-31 JP JP2022565737A patent/JP2023508616A/ja active Pending
- 2020-12-31 IL IL294441A patent/IL294441A/en unknown
- 2020-12-31 MX MX2022008183A patent/MX2022008183A/es unknown
- 2020-12-31 AU AU2020417305A patent/AU2020417305A1/en active Pending
- 2020-12-31 EP EP20911288.7A patent/EP4085137A4/en active Pending
- 2020-12-31 US US17/758,296 patent/US20230331804A1/en active Pending